Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer-Reference-Cited by-全球学者库

登录注册会员服务联系我们

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer

Published:2018-09 Issue: Volume:123 Page:91-98
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Garon Edward B.,Siegfried Jill M.,Stabile Laura P.,Young Patricia A.,Marquez-Garban Diana C.,Park David J.,Patel Ravi,Hu Eddie H.,Sadeghi Saeed,Parikh Rupesh J.,Reckamp Karen L.,Adams Brad,Elashoff Robert M.,Elashoff David,Grogan Tristan,Wang He-Jing,Dacic Sanja,Brennan Meghan^ORCID,Valdes Yacgley,Davenport Simon,Dubinett Steven M.,Press Michael F.,Slamon Dennis J.,Pietras Richard J.

Funder

National Institutes of Health

SPORE CDA FDP-NIH

NIH CTSI

One Ball Matt Memorial Golf Tournament

V Foundation for Cancer Research

UCLA Jonsson Comprehensive Cancer Center

Wolfen Family Lung Cancer Research Program

Stiles Program in Oncology, Hickey Foundation

National Lung Cancer Partnership, Genentech, AstraZeneca

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference56 articles.

1. Cancer statistics;Jemal;CA Cancer J. Clin.,2003

2. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat. Rev. Cancer,2007

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004

4. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N. Engl. J. Med.,2005

5. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-lung 3 and LUX-lung 6): analysis of overall survival data from two randomised, phase 3 trials;Yang;Lancet Oncol.,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer;Frontiers in Oncology;2023-08-28

2. Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer;Clinical Cancer Research;2023-06-07

3. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing;Genome Medicine;2023-03-03

4. Expression patterns and clinical significance of estrogen receptor in non-small cell lung cancer;Pathology - Research and Practice;2023-01

5. Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis;Cancers;2022-06-30

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3